Investing

Xeris Biopharma Holdings : XERS

XERS

Stock Data

$6.28

$0.16 (2.53%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Xeris Biopharma Holdings Inc is a Chicago-based biopharmaceutical firm focused on creating and bringing to market treatments for various medical conditions. Its flagship products include Gvoke, a ready-to-use glucagon for severe hypoglycemia; Keveyis, for primary periodic paralysis; and Recorlev, aimed at treating Cushing’s syndrome. Beyond these, Xeris is working on expanding its product range and applications through innovative technologies like XeriSol and XeriJect. Founded in 2005, the company is dedicated to addressing unmet medical needs.

All Xeris Biopharma Holdings Articles

1 Article

Joshua Rodriguez | Aug 30, 2024 at 10:20 AM EDT

3 Penny Stocks to Buy With $500

Are you interested in investing in penny stocks? Though doing so does come with risk, making the right investment decisions…